{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:07:54Z","timestamp":1768486074220,"version":"3.49.0"},"reference-count":71,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T00:00:00Z","timestamp":1507766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0186046","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T17:49:37Z","timestamp":1507830577000},"page":"e0186046","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Massive immune response against IVIg interferes with response against other antigens in mice: A new mode of action?"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2136-2388","authenticated-orcid":true,"given":"Laetitia","family":"Sord\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Spindeldreher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ed","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anette","family":"Karle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,10,12]]},"reference":[{"issue":"21","key":"ref1","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMra1009433","article-title":"Intravenous immune globulin in autoimmune and inflammatory diseases","volume":"367","author":"EW Gelfand","year":"2012","journal-title":"The New England journal of medicine"},{"issue":"19","key":"ref2","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.2146\/ajhp070582","article-title":"Unlabeled uses of intravenous immune globulin","volume":"65","author":"H Leong","year":"2008","journal-title":"American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists"},{"issue":"2\u20133","key":"ref3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12016-009-8155-9","article-title":"Evidence for the use of intravenous immunoglobulins\u2014a review of the literature","volume":"38","author":"S Kivity","year":"2010","journal-title":"Clinical reviews in allergy & immunology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1196\/annals.1423.044","article-title":"Intravenous immunoglobulin and cytokines: focus on tumor necrosis factor family members BAFF and APRIL","volume":"1110","author":"L Le Pottier","year":"2007","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1365-2567.2000.00949.x","article-title":"Neutralizing antibodies to granulocyte-macrophage colony-stimulating factor, interleukin-1alpha and interferon-alpha but not other cytokines in human immunoglobulin preparations","volume":"99","author":"M Wadhwa","year":"2000","journal-title":"Immunology"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1182\/blood.V93.11.3624","article-title":"Inhibition of cell adhesion by antibodies to Arg-Gly-Asp (RGD) in normal immunoglobulin for therapeutic use (intravenous immunoglobulin, IVIg)","volume":"93","author":"TL Vassilev","year":"1999","journal-title":"Blood"},{"key":"ref7","article-title":"Natural Autoantibodies to Fcgamma Receptors in Intravenous Immunoglobulins","author":"H Bouhlal","year":"2014","journal-title":"Journal of clinical immunology"},{"issue":"35","key":"ref8","doi-asserted-by":"crossref","first-page":"14104","DOI":"10.1073\/pnas.0700506104","article-title":"Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death","volume":"104","author":"TV Arumugam","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1172\/JCI117520","article-title":"High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments","volume":"94","author":"M Basta","year":"1994","journal-title":"The Journal of clinical investigation"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nm836","article-title":"F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins","volume":"9","author":"M Basta","year":"2003","journal-title":"Nature medicine"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2249.2010.04265.x","article-title":"Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris","volume":"162","author":"D Mimouni","year":"2010","journal-title":"Clinical and experimental immunology"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/intimm\/dxf099","article-title":"Efficacy of IVIG affinity-purified anti-double-stranded DNA anti-idiotypic antibodies in the treatment of an experimental murine model of systemic lupus erythematosus","volume":"14","author":"Y Shoenfeld","year":"2002","journal-title":"International immunology"},{"issue":"1\u20132","key":"ref13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jneuroim.2007.11.020","article-title":"A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis","volume":"194","author":"S Fuchs","year":"2008","journal-title":"Journal of neuroimmunology"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1172\/JCI24394","article-title":"Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases","volume":"115","author":"N Li","year":"2005","journal-title":"The Journal of clinical investigation"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1182\/blood.V98.10.3136","article-title":"Accelerated autoantibody clearance by intravenous immunoglobulin therapy: studies in experimental models to determine the magnitude and time course of the effect","volume":"98","author":"WK Bleeker","year":"2001","journal-title":"Blood"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1182\/blood.V100.6.2087","article-title":"Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia","volume":"100","author":"RJ Hansen","year":"2002","journal-title":"Blood"},{"issue":"24","key":"ref17","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1182\/blood-2011-08-374223","article-title":"The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody-mediated amelioration of murine immune thrombocytopenia","volume":"118","author":"AR Crow","year":"2011","journal-title":"Blood"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0037-1963(00)90104-5","article-title":"Fc receptor blockade and immune thrombocytopenic purpura","volume":"37","author":"JB Bussel","year":"2000","journal-title":"Seminars in hematology"},{"issue":"8877","key":"ref19","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0140-6736(93)92000-J","article-title":"Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura","volume":"342","author":"M Debre","year":"1993","journal-title":"Lancet"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1182\/blood.V98.4.1095","article-title":"Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia","volume":"98","author":"JL Teeling","year":"2001","journal-title":"Blood"},{"issue":"25","key":"ref21","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1182\/blood-2014-05-576835","article-title":"Inhibition of FcgammaR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcgammaRIIb in human macrophages","volume":"124","author":"SQ Nagelkerke","year":"2014","journal-title":"Blood"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1537-2995.2012.03725.x","article-title":"Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia","volume":"53","author":"T Tremblay","year":"2013","journal-title":"Transfusion"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/eji.201142260","article-title":"IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1","volume":"42","author":"I Schwab","year":"2012","journal-title":"European journal of immunology"},{"issue":"5503","key":"ref24","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.291.5503.484","article-title":"Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor","volume":"291","author":"A Samuelsson","year":"2001","journal-title":"Science"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1074-7613(03)00080-3","article-title":"Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease","volume":"18","author":"P Bruhns","year":"2003","journal-title":"Immunity"},{"issue":"12","key":"ref26","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1073\/pnas.0807319106","article-title":"Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy","volume":"106","author":"B Tackenberg","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2003-01-0023","article-title":"IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity","volume":"102","author":"AR Crow","year":"2003","journal-title":"Blood"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20051900","article-title":"Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors","volume":"203","author":"Y Kaneko","year":"2006","journal-title":"The Journal of experimental medicine"},{"key":"ref29","article-title":"Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs","author":"BM Fiebiger","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"22","key":"ref30","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1182\/blood-2012-03-415695","article-title":"Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fcgamma receptor for the amelioration of experimental ITP","volume":"119","author":"D Leontyev","year":"2012","journal-title":"Blood"},{"issue":"9","key":"ref31","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.4049\/jimmunol.1201965","article-title":"Intravenous gammaglobulin inhibits encephalitogenic potential of pathogenic T cells and interferes with their trafficking to the central nervous system, implicating sphingosine-1 phosphate receptor 1-mammalian target of rapamycin axis","volume":"190","author":"S Othy","year":"2013","journal-title":"Journal of immunology"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2141.2006.06245.x","article-title":"Reversal of immune thrombocytopenia in mice by cross-linking human immunoglobulin G with a high-affinity monoclonal antibody","volume":"135","author":"R Bazin","year":"2006","journal-title":"British journal of haematology"},{"issue":"9","key":"ref33","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.4049\/jimmunol.174.9.5837","article-title":"Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease","volume":"174","author":"J Abe","year":"2005","journal-title":"Journal of immunology"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2249.2012.04591.x","article-title":"Intravenous immunoglobulin does not increase FcgammaRIIB expression levels on monocytes in children with immune thrombocytopenia","volume":"169","author":"M Shimomura","year":"2012","journal-title":"Clinical and experimental immunology"},{"issue":"5787","key":"ref35","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1129594","article-title":"Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation","volume":"313","author":"Y Kaneko","year":"2006","journal-title":"Science"},{"issue":"5874","key":"ref36","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1154315","article-title":"Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc","volume":"320","author":"RM Anthony","year":"2008","journal-title":"Science"},{"key":"ref37","article-title":"Broad requirement for terminal sialic acid residues and FcgammaRIIB for the preventive and therapeutic activity of intravenous immunoglobulins in vivo","author":"I Schwab","year":"2014","journal-title":"European journal of immunology"},{"key":"ref38","article-title":"Dendritic cell immunoreceptor: A novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells","author":"AH Massoud","year":"2013","journal-title":"The Journal of allergy and clinical immunology"},{"key":"ref39","article-title":"Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity","author":"N Washburn","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"ref40","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1111\/j.1537-2995.2011.03517.x","article-title":"Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin","volume":"52","author":"D Leontyev","year":"2012","journal-title":"Transfusion"},{"key":"ref41","article-title":"Therapeutic Effect of IVIG on Inflammatory Arthritis in Mice Is Dependent on the Fc Portion and Independent of Sialylation or Basophils","author":"IK Campbell","year":"2014","journal-title":"Journal of immunology"},{"issue":"7","key":"ref42","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/eji.201444440","article-title":"Sialylation may be dispensable for reciprocal modulation of helper T cells by intravenous immunoglobulin","volume":"44","author":"S Othy","year":"2014","journal-title":"European journal of immunology"},{"issue":"9","key":"ref43","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.1073\/pnas.0900016106","article-title":"DC-SIGN and alpha2,6-sialylated IgG Fc interaction is dispensable for the anti-inflammatory activity of IVIg on human dendritic cells","volume":"106","author":"J Bayry","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.clim.2015.05.003","article-title":"Intravenous IgG (IVIG) and subcutaneous IgG (SCIG) preparations have comparable inhibitory effect on T cell activation, which is not dependent on IgG sialylation, monocytes or B cells","volume":"160","author":"AC Issekutz","year":"2015","journal-title":"Clinical immunology"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/gim.2011.4","article-title":"Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease","volume":"14","author":"YH Messinger","year":"2012","journal-title":"Genet Med"},{"issue":"6","key":"ref46","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/MBC.0000000000000304","article-title":"The use of intravenous immunoglobulin in immune tolerance induction in inherited haemophilia A: a single-centre experience and a review of literature","volume":"26","author":"P Kubisz","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"6","key":"ref47","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1542\/peds.100.6.e11","article-title":"Management of neutralizing antibody to Ceredase in a patient with type 3 Gaucher disease","volume":"100","author":"RO Brady","year":"1997","journal-title":"Pediatrics"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1167\/iovs.07-1175","article-title":"Interaction between bevacizumab and murine VEGF-A: a reassessment","volume":"49","author":"L Yu","year":"2008","journal-title":"Investigative ophthalmology & visual science"},{"issue":"5","key":"ref49","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.4049\/jimmunol.131.5.2254","article-title":"Relationship of germinal centers in lymphoid tissue to immunologic memory. VI. Transfer of B cell memory with lymph node cells fractionated according to their receptors for peanut agglutinin","volume":"131","author":"RF Coico","year":"1983","journal-title":"Journal of immunology"},{"issue":"4","key":"ref50","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.intimp.2005.11.015","article-title":"Adverse events associated with intravenous immunoglobulin therapy","volume":"6","author":"DJ Hamrock","year":"2006","journal-title":"International immunopharmacology"},{"issue":"4","key":"ref51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.autrev.2006.08.011","article-title":"Safety of intravenous immunoglobulin (IVIG) therapy","volume":"6","author":"U Katz","year":"2007","journal-title":"Autoimmunity reviews"},{"issue":"4","key":"ref52","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5415\/apallergy.2013.3.4.249","article-title":"Adverse events of intravenous immunoglobulin infusions: a ten-year retrospective study","volume":"3","author":"FR Palabrica","year":"2013","journal-title":"Asia Pacific allergy"},{"issue":"10","key":"ref53","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1345\/aph.1K198","article-title":"Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid","volume":"41","author":"HM Gurcan","year":"2007","journal-title":"The Annals of pharmacotherapy"},{"issue":"11","key":"ref54","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/intimm\/dxn090","article-title":"Immunomodulation of human B cells following treatment with intravenous immunoglobulins involves increased phosphorylation of extracellular signal-regulated kinases 1 and 2","volume":"20","author":"N Dussault","year":"2008","journal-title":"International immunology"},{"issue":"2","key":"ref55","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0896-8411(91)90028-B","article-title":"Stimulation of B and T cells by in vivo high dose immunoglobulin administration in normal mice","volume":"4","author":"A Sundblad","year":"1991","journal-title":"Journal of autoimmunity"},{"issue":"6","key":"ref56","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00005-009-0048-3","article-title":"CD40-activated B cells from patients with systemic lupus erythematosus can be modulated by therapeutic immunoglobulins in vitro","volume":"57","author":"S Neron","year":"2009","journal-title":"Archivum immunologiae et therapiae experimentalis"},{"issue":"8","key":"ref57","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2002-06-1684","article-title":"Intravenous immunoglobulins induce the in vitro differentiation of human B lymphocytes and the secretion of IgG","volume":"101","author":"MJ de Grandmont","year":"2003","journal-title":"Blood"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1006\/clim.2001.5004","article-title":"The B cell superantigen-like interaction of intravenous immunoglobin (IVIG) with Fab fragments of V(H) 3\u201323 and 3-30\/3-30.5 germline gene origin cloned from a patient with Kawasaki disease is enhanced after IVIG therapy","volume":"99","author":"S Leucht","year":"2001","journal-title":"Clinical immunology"},{"issue":"8","key":"ref59","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1182\/blood-2008-02-138073","article-title":"Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes"","volume":"112","author":"AS De Groot","year":"2008","journal-title":"Blood"},{"key":"ref60","article-title":"Tregitopes and impaired antigen presentation: Drivers of the immunomodulatory effects of IVIg?","author":"L Sorde","year":"2017","journal-title":"Immun Inflamm Dis"},{"issue":"2","key":"ref61","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.0818-9641.2004.01233.x","article-title":"CD4+ T cells cross-compete for MHC class II-restricted peptide antigen complexes on the surface of antigen presenting cells","volume":"82","author":"JD Hayball","year":"2004","journal-title":"Immunology and cell biology"},{"issue":"21","key":"ref62","doi-asserted-by":"crossref","first-page":"8647","DOI":"10.1073\/pnas.0811584106","article-title":"Abortive activation of CD4 T cell responses during competitive priming in vivo","volume":"106","author":"JM Weaver","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"32","key":"ref63","doi-asserted-by":"crossref","first-page":"12063","DOI":"10.1073\/pnas.0605130103","article-title":"CD8 T cell competition for dendritic cells in vivo is an early event in activation","volume":"103","author":"RA Willis","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"9","key":"ref64","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.4049\/jimmunol.161.9.4499","article-title":"Immunodominance in the CTL response against minor histocompatibility antigens: interference between responding T cells, rather than with presentation of epitopes","volume":"161","author":"EZ Wolpert","year":"1998","journal-title":"Journal of immunology"},{"issue":"7","key":"ref65","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1084\/jem.20041236","article-title":"Imaging the single cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes","volume":"200","author":"MJ Miller","year":"2004","journal-title":"The Journal of experimental medicine"},{"issue":"1","key":"ref66","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/icb.2013.69","article-title":"Control of TFH cell numbers: why and how?","volume":"92","author":"A Pratama","year":"2014","journal-title":"Immunology and cell biology"},{"issue":"4","key":"ref67","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1084\/jem.130.4.821","article-title":"Studies on antigenic competition","volume":"130","author":"NI Brody","year":"1969","journal-title":"The Journal of experimental medicine"},{"issue":"6","key":"ref68","first-page":"817","article-title":"Studies on antigenic competition. Effect of antigen dose on the immune response of mice injected simultaneously with human serum albumin and ferritin","volume":"23","author":"JM Rhodes","year":"1972","journal-title":"Immunology"},{"issue":"17","key":"ref69","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/0264-410X(95)00145-Q","article-title":"Immunological parameters associated with antigenic competition in a multivalent footrot vaccine","volume":"13","author":"JD Hunt","year":"1995","journal-title":"Vaccine"},{"issue":"3","key":"ref70","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.clim.2011.06.009","article-title":"Prevention of T cell activation by interference of internalized intravenous immunoglobulin (IVIg) with MHC II-dependent native antigen presentation","volume":"141","author":"E Aubin","year":"2011","journal-title":"Clinical immunology"},{"issue":"9","key":"ref71","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1182\/blood-2009-06-225417","article-title":"Indirect inhibition of in vivo and in vitro T-cell responses by intravenous immunoglobulins due to impaired antigen presentation","volume":"115","author":"E Aubin","year":"2010","journal-title":"Blood"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0186046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T02:20:23Z","timestamp":1693102823000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0186046"}},"subtitle":[],"editor":[{"given":"Jagadeesh","family":"Bayry","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,12]]},"references-count":71,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0186046","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,12]]}}}